Mike Kope

Occupation: Chief Executive Officer, SENS Foundation
Biography: Mike specializes in business development consulting. He currently serves as CEO of Genomic Systems, a company developing an anti-metastatic antibody for a wide range of cancers, and as officer and advisor for companies involved in genomic analysis, anti-aging research, vaccines and delivery technologies, research management systems, and genetic sequencing. Previously, Mike was Director of Corporate Development for MedImmune, Inc., serving the MedImmune Vaccines unit formerly known as Aviron. He came to Aviron a few years after having licensed the company its core FluMist™ technology from the University of Michigan, where he served as the University's Intellectual Property Counsel through the Nineties. Mike has negotiated a broad range of business acquisition and partnership agreements, designed strategies for technology protection and promotion in many fields of research, and facilitated a number of successful start-ups. He received his JD from the University of Michigan in 1990.